Sanara Capital
Israel · Series A → Series B
Their stated focus (public profile)
Sanara Capital is a dedicated Health-Tech fund established in 2023, focused on Digital Health, Bio-Convergence, and Medical Devices. It invests in Series A and B financing rounds of Israeli-related startups in Israel and abroad. It is a follow-on fund to Sanara Ventures, a seed-stage platform backed by Philips and Teva, and maintains a combined portfolio of nearly 20 active companies across both funds.
Stages: Series A → Series B
Sectors: Healthtech, Medtech
On file: 4 companies on record
Website: sanaracapital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.